Close

Drug Research

The Parenteral Drug Administration – An Evolving Spectrum

Parenteral drug administration has gone on to witness quite a significant set of advancements as well as transformations in recent years. This very crucial method when it comes to drug delivery happens to be playing a very pivotal role when...

Respiratory Syncytial Virus Jab From Moderna Gets FDA Nod

Moderna has gone on to announce in May 2023 that the US FDA has gone on to approve its respiratory syncytial virus- RSV vaccine, which is for adults aged 60 years and older. It is well to be noted that...

ChargePoint Technology launches new robotic solution to help transform the future of GMP manufacturing

ChargePoint Technology, a powder and liquid transfer specialist, has announced the launch of a new robotic material handling solution aimed at increasing safety and efficiency in solid dosage drug manufacturing. The new robotics solution will improve efficiency for manufacturers looking...

Meaningful Investment To Enable Tirzepatide API Production

It is well to be noted that a fresh $5.3 billion investment for pharma giant Eli Lilly and Company’s manufacturing site based in Lebanon, Indiana, US has gone on to raise the organization’s total investment in the country from...

Germany – Taking Right Steps Towards Pharma Drugs Reshoring

As part of its endeavors to throttle the pharma sector domestically, the German government has gone ahead with the adoption of a strategy paper in December 2023, which identified three major areas that need to be strengthened. The objectives include...

Green Chemistry Innovations Key To Pharma Solvent Sector

The pharmaceutical solvents sector has gone on to secure a valuation worth $3.9 billion in 2023 and is all set to scale the $6 billion mark by 2033 with a CAGR of 4.6% throughout the forecast period. Let us have...

Inside Out of The Pharmaceutical Fine Chemicals Segment

The pharmaceutical fine chemicals market is all set to showcase significant growth, with an increase from $136 billion in 2024 to an expected $233 billion by 2031. This surge is going to be driven by a CAGR of 8%...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read